Triglav Skladi D.O.O. Takes $3.66 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Triglav Skladi D.O.O. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 7,020 shares of the medical equipment provider's stock, valued at approximately $3,664,000.

Other large investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical in the fourth quarter valued at $82,517,000. Sycomore Asset Management grew its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after purchasing an additional 525 shares during the last quarter. Finally, Truist Financial Corp grew its holdings in Intuitive Surgical by 3.0% in the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock valued at $129,494,000 after purchasing an additional 7,298 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $10.09 during trading hours on Wednesday, hitting $547.07. 1,507,121 shares of the company's stock were exchanged, compared to its average volume of 1,645,687. The business's 50 day moving average is $509.36 and its 200-day moving average is $537.43. Intuitive Surgical, Inc. has a 12-month low of $396.15 and a 12-month high of $616.00. The firm has a market capitalization of $196.08 billion, a P/E ratio of 85.35, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the business posted $1.50 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have weighed in on ISRG. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Barclays lowered their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Citigroup increased their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Finally, Piper Sandler decreased their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 492 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $282,299.76. Following the completion of the sale, the senior vice president now directly owns 4,056 shares in the company, valued at approximately $2,327,251.68. The trade was a 10.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 2,401 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company's stock, valued at $205,093. This trade represents a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.